The S20G Substitution in HIAPP is More Amyloidogenic and Cytotoxic Than Wild-type HIAPP in Mouse Islets

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2016 Jul 10

PMID 27393137

Citations 22

Authors

Daniel T Meier

Leon Entrup

Andrew T Templin

Meghan F Hogan

Mahnaz Mellati

Sakeneh Zraika

Rebecca L Hull

Steven E Kahn

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: The S20G human islet amyloid polypeptide (hIAPP) substitution is associated with an earlier onset of type 2 diabetes in humans. Studies of synthetic S20G hIAPP in cell-free systems and immortalised beta cells have suggested that this may be due to increased hIAPP amyloidogenicity and cytotoxicity. Thus, using primary islets from mice with endogenous S20G hIAPP expression, we sought to determine whether the S20G gene mutation leads to increased amyloid-induced toxicity, beta cell loss and reduced beta cell function.

Methods: Islets from mice in which mouse Iapp was replaced with human wild-type or S20G hIAPP were isolated and cultured in vitro under amyloid-forming conditions. Levels of insulin and hIAPP mRNA and protein, amyloid deposition and beta cell apoptosis and area, as well as glucose-stimulated insulin and hIAPP secretion, were quantified.

Results: Islets expressing S20G hIAPP cultured in 16.7 mmol/l glucose demonstrated increased amyloid deposition and beta cell apoptosis, reduced beta cell area, decreased insulin content and diminished glucose-stimulated insulin secretion, compared with islets expressing wild-type hIAPP. Amyloid deposition and beta cell apoptosis were also increased when S20G islets were cultured in 11.1 mmol/l glucose (the concentration that is thought to be physiological for mouse islets).

Conclusions/interpretation: S20G hIAPP reduces beta cell number and function, thereby possibly explaining the earlier onset of type 2 diabetes in individuals carrying this gene mutation.

Citing Articles

The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity.

Esser N, Hogan M, Templin A, Akter R, Fountaine B, Castillo J Diabetologia. 2024; 67(9):1897-1911.

PMID: 39245780 PMC: 11410534. DOI: 10.1007/s00125-024-06161-0.

Delineating the Role of GxxxG Motif in Amyloidogenesis: A New Perspective in Targeting Amyloid-Beta Mediated AD Pathogenesis.

Sarkar D, Bhunia A ACS Bio Med Chem Au. 2024; 4(1):4-19.

PMID: 38404748 PMC: 10885112. DOI: 10.1021/acsbiomedchemau.3c00055.

Experimental Insights into Conformational Ensembles of Assembled β-Sheet Peptides.

Yu L, Wang R, Li S, Kara U, Boerner E, Chen B ACS Cent Sci. 2023; 9(7):1480-1487.

PMID: 37521785 PMC: 10375872. DOI: 10.1021/acscentsci.3c00230.

Pharmacological inhibitors of β-cell dysfunction and death as therapeutics for diabetes.

Dalle S, Abderrahmani A, Renard E Front Endocrinol (Lausanne). 2023; 14:1076343.

PMID: 37008937 PMC: 10050720. DOI: 10.3389/fendo.2023.1076343.

Analysis of Sheep and Goat IAPP Provides Insight into IAPP Amyloidogenicity and Cytotoxicity.

Miller M, Li M, Baghai A, Peetz V, Zhyvoloup A, Raleigh D Biochemistry. 2022; 61(22):2531-2545.

PMID: 36286531 PMC: 11132794. DOI: 10.1021/acs.biochem.2c00470.

References

Zraika S, Hull R, Udayasankar J, Aston-Mourney K, Subramanian S, Kisilevsky R . Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis. Diabetologia. 2009; 52(4):626-35. PMC: 2719780. DOI: 10.1007/s00125-008-1255-x. View

Westermark P, Engstrom U, Johnson K, Westermark G, Betsholtz C . Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A. 1990; 87(13):5036-40. PMC: 54256. DOI: 10.1073/pnas.87.13.5036. View

Sakagashira S, Sanke T, Hanabusa T, Shimomura H, Ohagi S, Kumagaye K . Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes. 1996; 45(9):1279-81. DOI: 10.2337/diab.45.9.1279. View

Aston-Mourney K, Hull R, Zraika S, Udayasankar J, Subramanian S, Kahn S . Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets. Diabetologia. 2011; 54(7):1756-65. PMC: 3220951. DOI: 10.1007/s00125-011-2143-3. View

Meier D, Entrup L, Templin A, Hogan M, Samarasekera T, Zraika S . Determination of Optimal Sample Size for Quantification of β-Cell Area, Amyloid Area and β-Cell Apoptosis in Isolated Islets. J Histochem Cytochem. 2015; 63(8):663-73. PMC: 4530400. DOI: 10.1369/0022155415585995. View

Cao P, Tu L, Abedini A, Levsh O, Akter R, Patsalo V . Sensitivity of amyloid formation by human islet amyloid polypeptide to mutations at residue 20. J Mol Biol. 2011; 421(2-3):282-95. PMC: 3388178. DOI: 10.1016/j.jmb.2011.12.032. View

Xu W, Jiang P, Mu Y . Conformation preorganization: effects of S20G mutation on the structure of human islet amyloid polypeptide segment. J Phys Chem B. 2009; 113(20):7308-14. DOI: 10.1021/jp8106827. View

Percy A, Trainor D, Rittenhouse J, Phelps J, Koda J . Development of sensitive immunoassays to detect amylin and amylin-like peptides in unextracted plasma. Clin Chem. 1996; 42(4):576-85. View

Jurgens C, Toukatly M, Fligner C, Udayasankar J, Subramanian S, Zraika S . β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition. Am J Pathol. 2011; 178(6):2632-40. PMC: 3123989. DOI: 10.1016/j.ajpath.2011.02.036. View

10.

Ma Z, Westermark G, Sakagashira S, Sanke T, Gustavsson A, Sakamoto H . Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide. Amyloid. 2002; 8(4):242-9. DOI: 10.3109/13506120108993820. View

11.

Scaglia L, Cahill C, Finegood D, Bonner-Weir S . Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology. 1997; 138(4):1736-41. DOI: 10.1210/endo.138.4.5069. View

12.

Hiddinga H, Sakagashira S, Ishigame M, Madde P, Sanke T, Nanjo K . Expression of wild-type and mutant S20G hIAPP in physiologic knock-in mouse models fails to induce islet amyloid formation, but induces mild glucose intolerance. J Diabetes Investig. 2014; 3(2):138-47. PMC: 4020731. DOI: 10.1111/j.2040-1124.2011.00166.x. View

13.

Sakagashira S, Hiddinga H, Tateishi K, Sanke T, Hanabusa T, Nanjo K . S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin. Am J Pathol. 2000; 157(6):2101-9. PMC: 1885776. DOI: 10.1016/S0002-9440(10)64848-1. View

14.

Seino S . S20G mutation of the amylin gene is associated with Type II diabetes in Japanese. Study Group of Comprehensive Analysis of Genetic Factors in Diabetes Mellitus. Diabetologia. 2001; 44(7):906-9. DOI: 10.1007/s001250100531. View

15.

Hull R, Andrikopoulos S, Verchere C, Vidal J, Wang F, Cnop M . Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes. 2003; 52(2):372-9. DOI: 10.2337/diabetes.52.2.372. View

16.

Hull R, Watts M, Kodama K, Shen Z, Utzschneider K, Carr D . Genetic background determines the extent of islet amyloid formation in human islet amyloid polypeptide transgenic mice. Am J Physiol Endocrinol Metab. 2005; 289(4):E703-9. DOI: 10.1152/ajpendo.00471.2004. View

17.

Gasa R, Gomis R, Casamitjana R, Novials A . High glucose concentration favors the selective secretion of islet amyloid polypeptide through a constitutive secretory pathway in human pancreatic islets. Pancreas. 2001; 22(3):307-10. DOI: 10.1097/00006676-200104000-00013. View